t(14;16)-positive multiple myeloma shows negativity for CD56 expression and unfavorable outcome even in the era of novel drugs.
Narita T, Inagaki A, Kobayashi T, Kuroda Y, Fukushima T, Nezu M, Fuchida S, Sakai H, Sekiguchi N, Sugiura I, Maeda Y, Takamatsu H, Tsukamoto N, Maruyama D, Kubota Y, Kojima M, Sunami K, Ono T, Ri M, Tobinai K, Iida S.
Narita T, et al. Among authors: kobayashi t.
Blood Cancer J. 2015 Feb 27;5(2):e285. doi: 10.1038/bcj.2015.6.
Blood Cancer J. 2015.
PMID: 25723856
Free PMC article.
No abstract available.